Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)

BACKGROUND: Riociguat is a soluble guanylate cyclase stimulator approved for pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTPEH). The objective of this study was to evaluate right heart size and function assessed by echocardiography during long term treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Marra, Alberto M., Halank, Michael, Benjamin, Nicola, Bossone, Eduardo, Cittadini, Antonio, Eichstaedt, Christina A., Egenlauf, Benjamin, Harutyunova, Satenik, Fischer, Christine, Gall, Henning, Ghofrani, Hossein Ardeschir, Hoeper, Marius M., Lange, Tobias J., Olsson, Karen M., Klose, Hans, Grünig, Ekkehard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299931/
https://www.ncbi.nlm.nih.gov/pubmed/30567595
http://dx.doi.org/10.1186/s12931-018-0957-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299931/
https://www.ncbi.nlm.nih.gov/pubmed/30567595
http://dx.doi.org/10.1186/s12931-018-0957-y

Ejemplares similares